Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- André Murad, PhD
Lifecenter Hospital
Principal Investigator - Carlos Augusto M. Beato, MD
Hospital Amaral Carvalho
Principal Investigator - Carlos G Ferreira, PhD
National Cancer Institute, France
Principal Investigator - Carlos Henrique E Barrios, MD
Pontifícia Universidade Católica do RS
Principal Investigator - Fábio Franke, MD
Hospital de Caridade de Ijuí - CACON
Principal Investigator - José Rodrigues, MD
Instituto do Câncer Arnaldo Vieira Carvalho - ICAVC
Principal Investigator - Mauro Zukin, MD
National Cancer Institute, France
Principal Investigator - Rogerio Lilenbaum, MD
The Mount Sinai Comprehensive Cancer Center
Principal Investigator - Ronaldo A Ribeiro, PhD
Instituto do Câncer do Ceará - ICC
Principal Investigator - Yeni Neron, MD
Centro de Pesquisas Oncológicas - CEPON
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto Do Câncer Do Ceará - Icc
Fortaleza, Ceará, Brazil
- Hospital Lifecenter
Belo Horizonte, Minas Gerais, Brazil
- Hospital Caridade de Ijuí - Cacon
Ijuí, Rio Grande do Sul, Brazil
- Hospital São Lucas
Porto Alegre, Rio Grande do Sul, Brazil
- Inca
Rio de Janeiro, Rio de Janeiro, Brazil
- Centro de Pesquisas Oncológicas - Cepon
Florianópolis, Santa Catarina, Brazil
- Hospital Amaral Carvalho
Jaú, São Paulo, Brazil
- Instituto Do Câncer Arnaldo Vieira de Carvalho
São Paulo, São Paulo, Brazil
- the Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2008
- Primary completion
- 31 Jan 2012
- Completion
- 31 Dec 2012
- Last update posted
- 22 Apr 2013
- Registered enrollment
- 228
- Registry id
- NCT01836575
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.